Anti-CD38重组抗体|科研级Daratumumab-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-CD38重组抗体|科研级Daratumumab

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-CD38重组抗体|科研级Daratumumab

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1199

Alias

科研级Daratumumab, Anti-CD38 Recombinant Antibody, Research Grade Daratumumab

Molecular Name

Daratumumab

Size

1mg, 5mg

CAS Number

945721-28-8

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Molecular Weight

148 kDa

Applications

WB, IP, IF, FuncS, FC, Neut, ELISAHuMax-CD38

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6466H9996N1724O2010S42

Target

CD38[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ